Colgate-Palmolive Company (NYSE:CL) Shares Bought by Praxis Investment Management Inc.

Praxis Investment Management Inc. lifted its holdings in Colgate-Palmolive Company (NYSE:CL - Free Report) by 15.2% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 23,937 shares of the company's stock after purchasing an additional 3,150 shares during the period. Praxis Investment Management Inc.'s holdings in Colgate-Palmolive were worth $2,243,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in CL. Brighton Jones LLC grew its holdings in shares of Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock valued at $962,000 after purchasing an additional 450 shares in the last quarter. Bernard Wealth Management Corp. purchased a new position in Colgate-Palmolive in the fourth quarter worth approximately $36,000. Private Advisor Group LLC lifted its stake in Colgate-Palmolive by 12.0% in the fourth quarter. Private Advisor Group LLC now owns 77,231 shares of the company's stock worth $7,021,000 after acquiring an additional 8,279 shares during the last quarter. Ieq Capital LLC lifted its stake in Colgate-Palmolive by 25.2% in the fourth quarter. Ieq Capital LLC now owns 58,008 shares of the company's stock worth $5,274,000 after acquiring an additional 11,666 shares during the last quarter. Finally, Forte Capital LLC ADV lifted its stake in Colgate-Palmolive by 3.4% in the fourth quarter. Forte Capital LLC ADV now owns 19,133 shares of the company's stock worth $1,739,000 after acquiring an additional 627 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock traded down $0.34 during trading on Friday, reaching $87.85. The company's stock had a trading volume of 9,572,245 shares, compared to its average volume of 4,794,174. The company has a 50-day moving average price of $91.50 and a two-hundred day moving average price of $90.80. The firm has a market cap of $71.19 billion, a PE ratio of 24.82, a P/E/G ratio of 4.68 and a beta of 0.38. Colgate-Palmolive Company has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The company has a current ratio of 0.85, a quick ratio of 0.54 and a debt-to-equity ratio of 8.96.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, April 25th. The company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. The business had revenue of $4.91 billion for the quarter, compared to analysts' expectations of $4.92 billion. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The company's quarterly revenue was down 3.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.86 EPS. On average, analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be issued a $0.52 dividend. The ex-dividend date is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.37%. Colgate-Palmolive's payout ratio is 58.76%.

Colgate-Palmolive declared that its Board of Directors has initiated a stock repurchase plan on Thursday, March 20th that permits the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization permits the company to repurchase up to 6.8% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's board believes its stock is undervalued.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on CL. JPMorgan Chase & Co. lifted their price target on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a research note on Monday, April 28th. UBS Group lifted their price target on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a research note on Thursday, April 17th. Wells Fargo & Company lifted their price target on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research note on Wednesday, April 2nd. Citigroup lifted their price target on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a research note on Monday, April 28th. Finally, Piper Sandler reduced their price objective on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a research report on Monday, March 31st. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive has a consensus rating of "Hold" and a consensus target price of $102.12.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.